Wordt geladen...
Pharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populations
Our aims were to summarize the clinical pharmacokinetics and pharmacodynamics of the dipeptidyl‐peptidase‐4 inhibitor, linagliptin, and to consider how these characteristics influence its clinical utility. Differences between linagliptin and other dipeptidyl‐peptidase‐4 inhibitors were also consider...
Bewaard in:
| Gepubliceerd in: | J Diabetes Investig |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217889/ https://ncbi.nlm.nih.gov/pubmed/27180612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12528 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|